This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pluristem’s Off-The-Shelf Placenta-Derived Cell Therapies - The Focus Of Presentations At Upcoming Investor And Medical Conferences

Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that its off-the-shelf placenta-derived cell therapies will be the focus of presentations at upcoming investor and medical conferences.

Chaya Mazouz, the company’s vice president of clinical and regulatory affairs, will present information about the regulatory study design considerations for PLX-PAD, the company’s lead cell therapy candidate for the treatment of critical limb ischemia (CLI), at 11 a.m. EDT on May 24 at the International Society for Cellular Therapy’s (ISCT) 16 th Annual Meeting in Philadelphia. She will also participate in a case study panel discussion: "Global Regulatory Perspectives Workshop", on May 23 at 3:15 p.m. EDT. Also at the meeting, Frida Grynspan, Pluristem’s vice president of research and development, will present an overview of the immunological profile of CLI patients following the intramuscular administration of PLX-PAD. Her presentation will take place at 10:45 a.m. EDT on May 25.

“We recently reported interim top-line results from our Phase I clinical trials demonstrating that PLX-PAD is safe, well tolerated and had improved the quality of life of CLI patients in the studies,” said Zami Aberman, Pluristem’s chairman and CEO. “With PLX-PAD, we have the unique opportunity to utilize a single source of cells, the placenta, to treat an unlimited number of CLI patients. Our presentations at the ISCT Annual Meeting and other conferences will highlight the potential of PLX-PAD as well as our core technology that enables the cost-effective development of cell therapies derived from the human placenta.”

At 1:15 p.m. EDT on June 1, Mr. Aberman will participate in a plenary session about the allogeneic approaches of cell therapy at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York. Hosted by National Securities Corporation and MD Becker Partners, SCIENCE is designed to unite investors with industry executives to exchange information and highlight opportunities in the stem cell universe. The event will bring together researchers, clinicians, business leaders, key investors and other stakeholders in the cell therapy space.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
PSTI $2.32 -0.43%
AAPL $114.64 -3.21%
FB $94.06 -0.08%
GOOG $629.25 -0.31%
TSLA $266.28 2.42%

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs